Pilbara Exploration Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- Fed: Nine Of 18 FOMC Participants Pencil In 2026 Rate Hike
- Delta Air Lines (DAL) Raises Quarterly Dividend 14.7% to $0.2150; 1% Yield
- ICC sets July 24 vote on whether to remove chief prosecutor Karim Khan, WSJ reports
Morgan Stanley Reiterates Equalweight Rating on Novo Nordisk (NOVOB:DC) (NVO)
June 23, 2025 1:35 PM EDTMorgan Stanley analyst Thibault Boutherin reiterated an Equalweight rating and DKK550.00 price target on Novo Nordisk (NOVOB:DC) (NYSE: NVO).
The analyst comments "H&H partnership termination (see press release here): Novo entered the arrangement with H&H before the 22 May (date of removal of sema from FDA shortage list) in order to facilitate the transition of patients on compounded semaglutide to Wegovy. Management reiterated that mass compounding and mass personalisation are against Novo's values and the direction they see for the market in the long term, and stated that Novo will not... More
